BENGALURU: The World Health Organization (WHO) said on Monday (Oct 18) it expects Bharat Biotech to provide more information on its COVID-19 vaccine, in a further setback to the Indian company’s hopes of getting an emergency-use listing for the shot.
Without WHO’s nod, the two-dose Covaxin is unlikely to be accepted as a valid COVID-19 vaccine around the world. Bharat Biotech has been pursuing a WHO emergency-use listing for several months, having submitted data on a rolling basis since July.
“We are aware that many people are waiting for the WHO’s recommendation for (Bharat Biotech’s) Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners,” WHO said on Twitter.
Bharat Biotech did not immediately respond to a Reuters request for comment.